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Abstract
Background: Microglia cells are the resident macrophages of the central nervous system and are considered its
first line of defense. In the normal brain, their ramified processes are highly motile, constantly scanning the
surrounding brain tissue and rapidly moving towards sites of acute injury or danger signals. These microglial
dynamics are thought to be critical for brain homeostasis. Under pathological conditions, microglial cells undergo
“activation,” which modifies many of their molecular and morphological properties. Investigations of the effects of
activation on motility are limited and have given mixed results. In particular, little is known about how microglial
motility is altered in epilepsy, which is characterized by a strong inflammatory reaction and microglial activation.
Methods: We used a mouse model of status epilepticus induced by kainate injections and time-lapse two-photon
microscopy to image GFP-labeled microglia in acute hippocampal brain slices. We studied how microglial activation
affected the motility of microglial processes, including basal motility, and their responses to local triggering stimuli.
Results: Our study reveals that microglial motility was largely preserved in kainate-treated animals, despite clear
signs of microglial activation. In addition, whereas the velocities of microglial processes during basal scanning and
towards a laser lesion were unaltered 48 h after status epilepticus, we observed an increase in the size of the
territory scanned by single microglial processes during basal motility and an elevated directional velocity towards a
pipette containing a purinergic agonist.
Conclusions: Microglial activation differentially impacted the dynamic scanning behavior of microglia in response
to specific acute noxious stimuli, which may be an important feature of the adaptive behavior of microglia during
pathophysiological conditions.
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Background
Microglia are the resident macrophages of the central
nervous system (CNS), acting as its first line of defense
to cordon off brain lesions, to phagocytize cellular deb-
ris, and to release signaling molecules critical for cell
survival [1].
Under physiological conditions, microglia show a uni-
form distribution and occupy distinct spatial domains
with minimal overlap [2]. A hallmark of microglia is
their highly dynamic and motile nature, which allows
them to react rapidly and intervene locally for effective
maintenance and control of brain homeostasis. Indeed,
they continuously scan the parenchyma of the brain in
an apparently random fashion (called basal motility),
rapidly extending and retracting their highly branched
processes [3–6] and contacting practically all other cell
types and neuronal compartments, including synapses
[7, 8].
In response to an acute lesion, microglia rapidly pro-
ject their processes towards sites of danger signals
(called directional motility; [3, 4, 9]), presumably to
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Due to their role as immune-competent cells, a variety
of signals are expected to attract microglial processes. In
particular, they are attracted by adenosine triphosphate
(ATP) and its derivatives. Indeed, activation of puriner-
gic receptors plays a major role for microglial dynamics
[3, 11]. In particular, extracellular ATP affects basal mo-
tility [3, 12], while activation of purinergic P2Y12 recep-
tors (P2Y12R) mediates directional motility induced by
laser lesions [13, 14].
Under pathological conditions, microglia change many
of their morphological and molecular properties through
a series of long-term transformations, called microglial
activation [15, 16]. Microglial activation plays a critical
role in the inflammatory reaction associated with a var-
iety of diseases, and it is a prominent feature in the brain
following status epilepticus (SE). SE is a seizure lasting
several minutes and that may occur in patients with a
history of epilepsy or as a consequence of a variety of in-
sults, such as trauma, febrile seizure, and stroke. The in-
flammatory reaction induced by SE may contribute to
the progression towards recurrent (chronic) epilepsy and
to common associated neuropsychiatric comorbidities
such as depression, memory impairment, and autism
spectrum disorders [17]. Microglial activation, which
plays a central role in orchestrating the inflammatory re-
action, is accompanied by morphological and functional
changes that may influence their motility and could thus
compromise their housekeeping capacities. In the con-
text of SE, it is unclear how microglial activation affects
the motility of microglia and their ability to respond to
noxious signals. A down- or up-regulation of microglial
motility is conceivable as microglia are known to retract
their processes and to exhibit boosted purinergic re-
sponses at the same time after SE [18–20].
To explore this question, we performed time-lapse
two-photon imaging of microglia in acute hippocam-
pal brain slices two days after induction of SE in
mice. We assessed the impact of microglial activation
on basal and directional microglial motility in re-
sponse to focal laser lesions as well as to local appli-
cation of an ATP analog.
Methods
Animals and SE model
All experiments followed Inserm and European Union and
institutional guidelines for the care and use of laboratory
animals (Council directive 2010/63/EU) and have been val-
idated by the local ethics committee of Bordeaux (n°
A50120200). The heterozygous CX3CR1+/eGFP mice used
in this study were obtained by crossing CX3CR1eGFP/eGFP
with C57BL/6 (Janvier, Le Genest Saint Isle, France) wild-
type mice. To avoid non-specific activation of microglia,
animals were kept in an animal facility free of specific
pathogenic organisms until the experiments.
To induce SE, 30- to 40-day-old male mice received
two intraperitoneal (i.p.) kainate (KA) injections (15 and
5 mg/kg) at an interval of 30 min. Littermate male mice
injected with PBS were used as control. The KA injec-
tions induced crises scored according to the Racine scale
of level 3 (rear into a sitting position with forepaws
shaking) to 5 (continuous rearing and falling). Mice,
which did not reach level 3 after 1 h received a third in-
jection (5 mg/kg). The multiple injection protocol pro-
vided a better control of the crisis and reduced mortality
(less than 10 %).
The overall crisis of each animal was evaluated accord-
ing to a modified Racine scale, which also considered
the duration of the crisis. The crisis was classified as
mild (level 2 of Racine’s scale: rigid posture with straight
and rigid tail), intermediate (level 3 of Racine’s scale,
duration shorter than 2 h), intense (level 3 of Racine’s
scale with episode 4 or 5, duration shorter than 3 h), or
severe (erratic behavior such as jumping or walking
backwards or crisis duration longer than 3 h).
Preparation of acute brain slices
Hippocampal slices were prepared 48 h after i.p. injec-
tions. Mice were sacrificed by cervical dislocation. The
brain was then quickly removed and placed in ice-cold
artificial cerebrospinal fluid (aCSF) saturated with carbo-
gen (95 % O2/5 % CO2) and in which NaCl was replaced
by sucrose (in mM: 210 sucrose, 2 KCl, 26 NaHCO3,
1.25 NaH2PO4, 10 glucose, 0.2 CaCl2, 6 MgCl2; pH 7.4,
osmolarity 310 mOsm). Transverse 350-μm-thick slices
were cut using a vibratome (VT1200, Leica, Mannheim,
Germany), transferred to a heated (33 °C) holding cham-
ber containing carbogenated (95 % O2/5 % CO2) stand-
ard aCSF (in mM: 124 NaCl, 3 KCl, 26 NaHCO3, 1.25
NaH2PO4, 10 glucose, 2 CaCl2, 1 MgCl2, pH 7.4, osmo-
larity 305 mOsm/L) for 45 min, and then maintained
until the experiment at room temperature for a max-
imum of 3 h.
Time-lapse two-photon imaging
Individual slices were transferred to a submerged record-
ing chamber and continuously perfused with carbogenated
aCSF (3 ml/min) at 33 °C. Images were acquired with a
40X water immersion objective (NA 1.0), using a
commercial upright two-photon laser-scanning fluores-
cence microscope (Ultima, Prairie Technologies, Middle-
ton, Wisconsin, USA and Axio Examiner, Zeiss,
Oberkochen, Germany). For two-photon excitation, a
Ti:Sapphire laser (Mai Tai, Spectra-Physics, Darmstadt,
Germany) was tuned to 900 nm. Four-dimensional image
stacks (x, y, z, t) were acquired in the strata radiatum/lacu-
nosum-moleculare in the CA1 area of the hippocampus.
The voxel size was 200 × 200 × 1000 nm3 in all experiments
measuring basal motility and responses to laser lesion,
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while it was 300 × 300 × 1000 nm3 in most of the experi-
ments with the ATP analog. The z-stacks were 11 to 25 μm
thick and acquired at intervals between 25 and 60 s. We
did not detect any signs of photo-induced damage during
extended time-lapse acquisitions lasting up to 1 h.
To induce a small laser lesion, a region of 1.6 × 1.6 μm
was repeatedly illuminated for 20–50 times with an ele-
vated intensity of the two-photon laser, which reliably
induced a microglial response.
A puff of the P2Y12R agonist 2-Methylthioadenosine
diphosphate trisodium salt (2Me-ADP, 100 μM) was ap-
plied by manual pressure through a glass pipette gently
inserted in the slice to limit mechanical damage. No
microglial responses were observed when a pipette con-
taining aCSF was inserted and a similar pressure was
applied.
To reduce effects from the slicing procedure, we imaged
microglia that were fully embedded in the brain slice, at
least 50 μm below the surface of the slice, which is a depth
where neurons are usually intact [21]. At this imaging
depth, microglial morphology was comparable to what
has been observed in perfusion-fixed animals (data not
shown) and in vivo [3, 4]. Furthermore, in our experimen-
tal conditions, basal motility was similar to what has been
reported for cortex and spinal cord in vivo [3, 4, 9].
Image analysis
Analysis was carried out with ImageJ (National Institute
of Health). Analysis of microglial cell body size was per-
formed on maximal intensity projection images, consid-
ering only the cells having the cell soma fully contained
within the 3D image stack. Image analysis was done
blindly with respect to crisis level. In order to avoid sub-
jective interpretation of the crisis level, only scores by
the same person were considered for the correlation be-
tween crisis level and microglial morphology. Cell bodies
were measured using the “magic wand” tool in ImageJ
on the maximal intensity projection image. When ob-
jects from a different focal plane contaminated the
measurement, a subset of images containing only the
cell body was used for the projection. The number of
primary processes was assessed in 3D stacks. The lon-
gest process was verified in the 3D stack, then drawn by
hand and measured in the 2D projection. Images of
microglia were taken in two to three hippocampal slices
per animal. Morphological parameters were measured in
all images, and the median was taken as a representative
value of each animal. To assess the relationship between
cell body size and dynamics, the median of cell body
measurements per slice in each experiment was taken as
representative value.
To compensate for x-y movements, images of the tem-
poral series were aligned using the following ImageJ
plug-ins: StackReg, MultistackReg, and PoorMan3Dreg
[22]. To analyze the movement of single processes, the
plug-in MtrackJ [23] and custom written programs in
MATLAB (MathWorks, France) were used. Each move-
ment was classified as elongation, retraction, or station-
ary, according to its velocity relative to a fixed reference
point (lesion site or pipette tip for directional motility).
In the case of basal motility, the reference point was de-
fined by where the process emerged from the parent
process. The territory explored was calculated as
maximum-minimum distance from the point of
reference.
To estimate the overall velocity at which the fluorescent
processes elongated towards the target (pipette or laser le-
sion site), a series of concentric circles were drawn as a re-
gion of interest and the fluorescence was measured in
concentric rings (Additional file 1: Figure S1). The velocity
was defined as the distance between two rings divided by
the time between their maxima of the fluorescence signal.
We considered only the experiments in which we could
clearly identify at least three peaks of fluorescence in three
coronal sections, thus two velocities, and the mean was
taken as the representative velocity of each experiment
(Additional file 1: Figure S1).
The territory explored by a single process was calculated
as the linear distance between the most distant and closest
points reached by a single process with respect to its par-
ent branch, irrespective of elongation or retraction. For
each slice, 7–10 processes from several cells were analyzed.
Statistics
Data values are presented as mean ± SEM or median with
quartile. Statistical significance was established with statis-
tical tools in MATLAB or Origin (OriginLab, RITME
Informatique, France). First, we tested whether data were
sampled from populations that follow Gaussian distribu-
tions using the method of Kolmogorov and Smirnov.
For sample populations with non-Gaussian and Gaussian
distributions, a non-parametric (Mann-Whitney) or para-
metric tests (t test with Welch’s correction) were used to
assess differences in the median (or mean). In case of
paired data, the non-parametric Wilcoxon signed-rank
test was used. The Kolmogorov and Smirnov test was
used to compare distributions of pooled values across all
experiments between two groups of animals. Statistical
significance was established at p < 0.05 and p < 0.01. N
represents the number of animals, while n represents the
number of cells, experiments, or processes as indicated in
the text.
Results
Microglial activation after status epilepticus
We imaged microglia in acute hippocampal brain slices
from Cx3Cr1+/eGFP mice by two-photon microscopy and
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analyzed their morphological dynamics. As previously
described [18, 21, 24], 48 h after injection, we observed
an increase in the number of microglia in KA-treated
animals, indicative of microglial activation. Furthermore,
in KA-treated animals, microglial cell bodies were sub-
stantially larger and processes were shorter compared to
control animals (Fig. 1a, b). We checked whether the de-
gree of morphological changes after SE induction corre-
lated with the severity of SE, as classified according to a
modified Racine scale (see Methods for details). While
no significant differences in cell body sizes were ob-
served between control (n = 163, N = 10) and animals
with mild seizures (n = 21, N = 2, KS test, p = 0.29), the
cumulative probability plot of the distribution obtained
from animals with intermediate (n = 106, N = 5), intense
(n = 43, N = 4), and severe seizures (n = 126, N = 8, KS test,
p < 0.01, compared to previous level; Fig. 1c, d) was pro-
gressively shifted to the right. Moreover, in experiments
where the animals exhibited intense and protracted sei-
zures, microglia took on an amoeboid shape and migrated
to the pyramidal cell body layer (Additional file 2: Figure
S2). Microglial cell shape varied widely in KA-treated ani-
mals, even within the same slice. The variation was larger
for severe crises, where we could observe hyper-ramified
cells, as well as amoeboid-like shapes. We analyzed two
morphological parameters: the number of primary pro-
cesses and the longest process identifiable in each cell.
The number of primary process was not statistically differ-
ent between the control (median 6, n = 85) and animal
with intermediate seizure (median 5.5, n = 56; KS test
0.99), while it was different between control animals and
animals with severe seizure (median 7, n = 36; KS test
0.028). Similar to cell body size, we observed a progressive
behavior, with the process length shifting towards smaller
values for more intense crises (Fig. 1f, h). The median
values were 38.5, 31.8, 26, and 22 μm for control (n = 96,
N = 10), intermediate (n = 91, N = 5), intense (n = 49, N =
4), and severe (n = 115, N = 8) crisis levels, respectively.
All distributions were significantly different from the re-
spective previous level (KS < 0.01), except between the se-
vere and intense crisis (KS = 0.08). These results are in
general agreement with changes reported in the literature
in different animal models [24–27].
Taken together, these results show that there is a
strong correlation between seizure severity and morpho-
logical changes (Fig. 1e–h), indicating that cell body size
can be used as a reliable proxy of seizure intensity and
microglial activation.
Effect of microglial activation on basal motility of
microglial processes
To establish whether and how microglial activation in-
duced by SE affects the ability of microglia to patrol brain
parenchyma, we tracked the morphological dynamics of
microglial processes by time-lapse two-photon imaging in
acute hippocampal slices.
First, we analyzed the motility of microglial processes
under baseline conditions in control and KA-treated ani-
mals (Fig. 2). To this end, we measured the average vel-
ocity of the tips of individual microglial processes based
on the maximal intensity projections of 3D image stacks
acquired every 45 s for up to 8 min.
The average tip velocity was indistinguishable between
KA-treated and control tissue (ctrl: 2.38 ± 0.08 μm/min,
N = 7; KA: 2.46 ± 0.10 μm/minN = 6; p = 0.58, t test).
Similarly, no difference was found between the velocity
distributions of all processes for the two groups (Fig. 2b;
ctrl: n = 89; KA: n = 71; KS = 0.99), despite the significant
difference in their average cell body size (ctrl: 42.2 ±
2.5 μm2; KA: 73.5 ± 9.1 μm2; p = 0.004), confirming that
KA injections indeed had induced microglial activation.
Performing extended time-lapse imaging experiments
(acquiring 3D image stacks every 30 s for up to 30 min),
we also analyzed the speed at which individual microglial
processes elongated and retracted, which is a more re-
fined measure of microglial process motility. Comparing
elongation and retraction velocity in the same process
did not turn up any significant differences, neither in
control (p = 0.46; Wilcoxon signed-rank test; n = 51 pro-
cesses; obtained in experiments in three animals) nor
KA-treated animals (p = 0.95; Wilcoxon signed-rank test;
n = 136 processes; obtained in nine experiments in five
animals; data not shown).
Finally, we determined the size of the territory ex-
plored by microglial processes as the maximal linear
covered distance (see Methods for details). The size of
the territory was highly variable (ranging from 1 to
15 μm). Yet, on the whole, microglial processes explored
a significantly larger territory in KA-treated than in
control animals (median ctrl: 4.18 μm; n = 51 pro-
cesses; n = 3 experiments; three animals; median KA:
5.38 μm; n = 152 processes; n = 9 experiments; five an-
imals; p = 0.019; Fig. 2c). Moreover, there was a
strong positive correlation between microglial cell
body size (median value per animal) and the average
distance covered by microglial processes in KA-
treated animals (r = 0.8; Fig. 2d).
Taken together, our analysis indicates that basal motil-
ity of microglia was preserved after microglial activation.
Microglial processes moved at the same speed but cov-
ered a larger distance in KA-treated animals as com-
pared with control animals.
Directional motility towards a pipette containing P2Y12R
agonist
We next assessed the ability of activated microglia to
rapidly react to potentially noxious signals. Consistently
with previous reports, microglial processes were attracted
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Fig. 1 (See legend on next page.)
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by ATP analog 2Me-ADP (Additional file 3; Additional file
4), an agonist of P2Y12R, while cell bodies did not move
during the observation time (up to 1 h) [3, 13, 18, 28]. We
tracked individual microglial processes during their move-
ments towards a patch pipette containing the P2Y12R
agonist. We observed that it took microglial processes
about half the time to reach the pipette tip in KA-treated
animals compared to control experiments (ctrl: 58.2 ±
5.7 min, n = 6, N = 4; KA: 29.0 ± 3.7 min, n = 6, N = 4; p <
0.01, t test; Fig. 3a), confirming a previous study based on
wide-field imaging in acute brain slices [18].
In two KA experiments, microglial processes failed to
be attracted by the 2Me-ADP-containing pipette. In both
cases, slices were obtained from mice, which had under-
gone particularly strong crisis and whose microglia
showed signs of extreme activation. Indeed, their cell
bodies were very large and fragmented and mostly de-
void of processes (Additional file 2: Figure S2), suggest-
ive of strong phagocytic activity. This data set was
excluded from the statistical analysis of the morpho-
logical dynamics.
To analyze the directional motility in greater details,
we compared the distributions of all elongation steps
made by single microglial processes. The distribution
observed in KA-injected animals was substantially
shifted to the right compared to the control case, indi-
cating increased velocity (ctrl: median 1.49 μm/s, n = 1450
movements; KA: median 2.25 μm/s, n = 740 movements;
KS test, p < 0.001; Fig. 3b). We then calculated the mean
velocity of several single processes in each experiment
(Fig. 3c), which confirmed the difference between the two
experimental groups (t test, p < 0.01). Similar results were
obtained by measuring the fluorescence of microglial pro-
cesses passing through concentric rings drawn around the
pipette (global velocity, see the “Methods” section for de-
tails). The mean velocity was 1.30 ± 0.17 μm/min (n = 6)
for the control group and 2.68 ± 0.22 μm/min (n = 5) for
the KA group (p < 0.01, t test; Fig. 3c).
The analysis of single processes revealed that some of
them abruptly stopped and retracted and/or started to
scan the territory in an apparent random fashion, even
though initially they appeared to move towards the pip-
ette tip. Therefore, we compared the retraction velocity
between KA-treated and control animals. In contrast to
elongation velocity, the distributions of retracting velocity
were not statistically different (ctrl: median 1.38 μm/min,
n = 97; KA median 1.73 μm/min, n = 57; p = 0.18, KS test).
Consistently, elongation was more rapid than retraction in
the KA group (p < 0.001, KS test), while in the control
group elongation and retraction were not statistically dif-
ferent (p = 0.19, KS test; data not shown).
Taken together, our analysis shows that microglial acti-
vation affected the motility of microglial processes to-
wards a pipette containing a purinergic agonist by
specifically boosting the elongation speed, while the re-
traction speed was unaltered.
Directional motility towards a laser lesion
In order to assess how microglial activation affects the
ability of microglia to direct their processes towards sites
of acute physical injury in brain tissue, we induced a
laser lesion in a small region (1.6 × 1.6 μm) and mea-
sured the velocity of microglial processes moving to-
wards the lesion site. Laser lesions have been used
before in in vivo [3, 4] and acute slice studies [10]. In
agreement with previous reports, we observed that many
microglial processes rapidly switched from a basal scan-
ning mode to directional motility towards the lesion site
(Fig. 4a, Additional file 5; Additional file 6). In many in-
stances, newly formed processes grew out from the cell
body and from existing processes and moved towards
the lesion site. Similar to the case of the ATP analog, cell
bodies did not move during observation time (up to
30 min). The number of processes involved in the re-
sponse was highly variable between experiments, depend-
ing on the distance to the lesion site and presumably also
on the type of the affected region (e.g., neuronal dendrites
or soma, astrocyte, blood vessel).
Microglial processes typically reached the lesion site
within a few minutes (examples in Fig. 4a, Additional
file 5; Additional file 6) for both experimental groups
(ctrl: median values 4.23 min; n = 9, N = 6; KA: 4.48 min;
n = 11, N = 6; p = 0.17; Mann-Whitney test), even though
their median cell body sizes were substantially different
(ctrl: 38.6 ± 2.64; KA: 64.7 ± 5.8; p = 0.001).
(See figure on previous page.)
Fig. 1 Cell body size correlates with the severity of status epilepticus. a, b Maximal intensity projection (MIP, z = 19 μm) images of microglial cells
obtained in control mice (a) and in mice two days after kainate i.p. injection (b). The insets show higher magnification images. The line around
cell bodies was drawn in a semi-automatic way to measure cell body size. The line on the process was based on the 3D image stack to avoid projection
artifacts. Note the increase in cell body size of microglia and decrease of the longest process after SE. Scale bars 10 and 6 μm in the insets. c Soma size
measurements obtained in all experiments classified according to the crisis level of animals, their median, and quartile value. d Cumulative probability
of cell body size grouped according to the crisis level of animals, scored according to modified Racine’s scale. Note the progressive shift to the right
with the increase of the severity of the induced SE. e Relationship between the median of cell body size for each animal and its crisis level or in control
(ctrl, black). f Measurements of longest processes obtained in all experiments classified according to crisis level of animals, their median, and quartile
value. g Cumulative probability of data represented in (f) grouped according to crisis level. Note the progressive shift to the left with increasing crisis
severity. h Relationship between the median of the longest processes for each animal and its crisis level or in control (ctrl, black)
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We then analyzed the global and elongation velocity of
each process induced by the laser lesion. The elongations
made by all analyzed processes did not show any statisti-
cally significant differences between the experimental
groups (ctrl: median 3.84 μm/s; n = 817 movements, N = 6;
KA: median 3.99; n = 1231 movements, N = 6; p = 0.4; KS
test; Fig. 4b). Similarly, no statistically significant difference
was found in the elongation velocity measured in each ex-
periment (assessed as a mean of single processes) (ctrl:
4.22 ± 0.23 μm/min, n = 9, N = 6; KA: 4.53 ± 0.26 μm/min;
n = 10, N = 6, p = 0.40, t test; Fig. 4c). Likewise, no differ-
ences were observed for global velocity between the experi-
mental groups (ctrl: 3.75 ± 0.43 μm/min, n = 7; KA: 4.16 ±
0.2 μm/min, n = 9; p = 0.38, t test; Fig. 4c).
Fig. 2 Activated microglia scan larger territory, without changing their velocity. a Maximal intensity projection of time-lapse two-photon images
at different time points during spontaneous movements of microglial processes in control (left column) and 48 h after induction of SE (right column).
The figure shows retracting (red symbols) and elongating processes (green symbols), with the starting/arriving points marked by circles. Scale bar, 5 μm.
b Cumulative probability of all elongation movements by single process tips measured in control (black) and KA-injected (red) animals shows no
difference between the two groups (p = 0.99, KS test). c Cumulative probability of territory explored by all single process tips measured in control
(black) and KA-injected (red) animals. p = 0.019, KS test. d Relationship between the median of explored territory by microglial processes versus the
median of the cell body size in each experiment. The red line represents the linear fit (r = 0.8)
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In summary, unlike the elevated directional motility
towards a 2Me-ADP-containing pipette, the velocity to-
wards a laser lesion was not measurably affected by
microglial activation.
Spatial extent of microglial responses to 2Me-ADP and
laser lesions
In our experimental conditions, the velocity of the direc-
tional motility induced by laser lesions was roughly three
times higher than the velocity induced by the P2Y12R
agonist. However, the time it took to completely sur-
round the pipette tip was almost 15 times longer than
the time to surround the lesion site. To better
understand this apparent discrepancy, we characterized
in more detail the effects of 2Me-ADP application and
laser lesions on directional motility.
We determined the spatial extent of the microglial re-
action, i.e., the area over which microglial processes
responded to a locally applied trigger stimulus.
Microglial processes were attracted over large distances
in response to 2Me-ADP (ctrl: >100 μm, Additional file 3).
By comparison, the distance was much smaller for laser
lesions (laser maximal distance, ctrl: 35.8 ± 1.7 μm, n = 9,
Fig. 4d). Interestingly, not all processes that initially
responded (responding process) actually reached the tar-
get area (arriving process), both for 2Me-ADP application
Fig. 3 Faster process motility of activated microglia towards a pipette containing 2Me-ADP. a Maximal intensity projection of two-photon images
at different time points after the insertion (at t = 0) of a pipette containing 2Me-ADP (100 μM) in slice from control (left column) or kainate-treated
(right column) animals. At t = 25 min (right column), the processes of activated microglia have reached the pipette (bottom images), whereas those
of microglia from control mice reached their target only after 45 min (inset picture). Scale bar, 15 μm. b Cumulative probability of all elongation
movements by single process tips measured in control (black) and KA-injected (red) animals (p < 0.001, KS test). c Velocity measured with two dif-
ferent methods in control (black) and KA-injected (red) animals. Global velocity was assessed measuring the fluorescence in concentric rings
around the pipette tip. Process elongation velocity was evaluated considering the median of average elongation tip velocity of several processes
in the experiment. Both methods revealed a higher velocity in KA-injected animals compared to control (p < 0.01, t test)
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Fig. 4 Microglial activation does not affect process motility towards a laser-induced lesion. a Examples of maximal intensity projection of two-
photon images at different time points after the induction of lesion with a laser in a small portion of the slice (red square) in control (left column)
and in KA-injected (right column) animal. Scale bar, 10 μm. b Cumulative probability of all elongation movements by single process tip measured
in control (black) and KA-injected (red) animals. p = 0.17, KS test. c Global velocity and process elongation velocity measured in control (black) and
KA-injected animals (red). None of the two methods shows a statistically significant difference between the two groups (p = 0.38 and 0.40 for
global and process elongation, respectively, t test). d Evaluation of the area of influence of the laser lesion in control (black) and KA-injected (red)
animals. Each dot represents the most distant process that still reacted to the lesion (responding processes) or actually arrived at the lesion site (arriving
processes). None of the two groups showed a statistically significant difference (p = 0.39 and p = 0.16 for responding and arriving, respectively, t test)
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and laser lesion (maximal distance arriving process, ctrl:
20.8 ± 2.4 μm, n = 9, Fig. 4d). The maximal distance of
arriving or responding processes was not significantly
different in KA-treated animals (p = 0.38 for responding,
p = 0.16 for arriving), suggesting that despite the dramatic
changes in morphology, the response zone of microglia to
a laser lesion was not affected.
Interestingly, the responses to 2Me-ADP application
frequently seemed to be coordinated among processes
from different microglia. We observed that processes,
which were closer to the pipette, started to move only
after the more distal ones had caught up with them
(Additional file 3; Additional file 4; Additional file 7:
Figure S3), both in the control and KA groups. By com-
parison, this striking effect of coordination across many
microglia cells in response to the ATP analog was much
less obvious in the response to laser lesions, where
microglial processes rushed to the lesion site more pre-
cipitously (Additional file 8: Figure S4, Additional file 5;
Additional file 6).
Thus, 2Me-ADP application and laser lesions both ef-
fectively triggered microglial directional motility. However,
the responses to these two triggers differed with respect to
their sensitivity to/modulation by SE, their velocity, and
the spatial extent of their responses as well as the level of
coordination in their collective behavior, which resulted in
large differences in the time to reach the target.
Discussion
Microglia play a critical role in the health and homeostasis
of the CNS. One of their main responsibilities is to avert
impending threats by continuously scanning brain paren-
chyma and removing noxious substances and cellular deb-
ris that would otherwise accumulate and disrupt brain
physiology. This ability is particularly important during
neurodegenerative diseases when neural cell death and
damage are rampant. Thus, it is important to understand
how microglial motility is affected by pathological states.
Using time-lapse two-photon imaging in acute brain
slices, we examined in detail the ability of microglia to
scan brain tissue and to respond to acute danger signals in
the context of an animal model of SE. We observed that
the basal velocity of microglial processes and their direc-
tional motility towards a laser lesion were unaffected,
while the size of the territory scanned by individual micro-
glial processes and their velocity towards a source of ATP
analogs were markedly increased after the induction of SE.
Our experiments indicate that microglial motility was not
compromised by the activation of microglia caused by the
induction of SE. Instead, microglial activation resulted in
an enhanced scanning behavior, which may represent a
state of heightened vigilance.
The mechanisms underlying microglial motility are
not well understood yet. However, purinergic signaling
seems to play a major role [6, 11]. The ATPase apyrase
and the purinergic antagonist suramin both slow down
baseline motility, while ATP increases it [3, 12]. Direc-
tional motility towards laser lesion strongly depends on
P2Y12R, since it is almost abolished in P2Y12R knock-
out animals [13, 14]. Forty-eight hours after SE, P2Y12R
are up-regulated [18], which would be expected to lead
to an increase in directional motility. Here, we con-
firmed that the velocity towards a pipette containing the
P2Y12R agonist is indeed increased. Surprisingly, we did
not find any difference in directional motility between
KA-injected and control animals in response to laser le-
sions. However, the two types of directional motility
could be mediated by different mechanisms. While the
P2Y12R agonist activates a specific signaling pathway,
laser lesions are a blunter trigger, which is likely to en-
gage multiple signaling pathways that define the micro-
glial response. Microglial dynamics depend on actin
polymerization [10]. In other cell types, motility and
actin polymerization are largely controlled by small
GTPases [29–31], which can be differently modulated by
the activation of several receptors, including purinergic
receptors [32, 33]. Thus, stimulation of different micro-
glial membrane receptors may induce distinct forms of
directional motility. Consistently, the spatial extent and
collective behavior of microglial processes were quite
distinct for the two types of induced directional motility.
Furthermore, the velocity of the processes was higher
for laser lesions than in response to the ATP analog, and
it might have been already at the maximal speed the cell
could sustain. Indeed, as far as we know, no increase in
the velocity of laser-induced directional motility has
been reported following any type of treatment.
The relationship between activation and motility has
been investigated before in several mouse models of
neurological disorders, showing highly heterogeneous re-
sults. In amyotrophic lateral sclerosis (ALS) at the pre-
clinical stage, basal motility was reported to be similar to
control, while the response to laser lesion involved more
microglial processes, which moved with unaltered vel-
ocity [34]. However, at the clinical stage, amoeboid and
activated microglia reportedly showed reduced injury-
directed response as well as reduced basal motility [34].
In contrast, in an Alzheimer’s model, microglial pro-
cesses moved faster towards an ATP-containing pipette
[35], while responses to a laser lesion and phagocytosis
were impaired [36], and basal motility remained un-
affected [37]. A low dose of intraperitoneal injection of
lipopolysaccharide (LPS), which activates microglia,
showed no effects after two days on basal motility in
vivo [38], although a decrease was observed 2 h after in-
jection in acute slices [39]. However, higher LPS doses
increased basal motility without affecting the time to
reach the site of the laser lesion [40]. Interestingly, the
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relationship between activation and actin dynamics may
be bi-directional, since impairment of actin dynamics
shapes microglial functions [41].
Thus, the effects of microglia activation on motility
cannot be easily generalized, because they unfold dy-
namically over time and depend strongly on the disease
model. Furthermore, the type of motility must be taken
into account when comparing different models, because
they may be differently affected by microglial activation
as our experiments demonstrate. We speculate that dif-
ferential expression of P2Y12R may partially account for
the variety in observations, as it seems to vary with acti-
vation status and mode of activation. On the one hand,
enhanced P2Y12R expression is observed in the spinal
cord three days after partial sciatic nerve ligation [42], as
well as in human microglia under pathological condi-
tions that promote alternative activation (M2; IL4- and
IL-13, [43]). On the other hand, in post-mortem samples
from the cerebral cortex of patients with multiple scler-
osis (MS), P2Y12R expression is absent in microglia
within the lesion zone [44]. Consistently, it gradually de-
creases in ALS and MS animal models [45]. Similar ef-
fects are observed when microglia activation is induced
by LPS [13]. Thus, high activation characterized by an
amoeboid shape may diminish P2Y12R expression. The
lack of response in this study to a P2Y12R agonist in
slices obtained from two animals, which had undergone
a particularly long and severe crisis, is consistent with
this hypothesis.
In addition to the velocity of microglial processes, it is
important to consider the territory they explore, because
it may influence their ability to interact with each other.
Under physiological conditions, microglial processes
hardly ever come into physical contact with each other.
The avoidance behavior is abandoned when they detect
danger signals and act together to isolate the source of
the putative problem, implying that their mutual repul-
sion is dynamically regulated.
After SE, the spatial distribution of microglia was al-
tered. Besides the twofold increase in the number of
microglia [18], several cell bodies and cellular processes
were found in the immediate proximity of each other
(Additional file 9: Figure S5), which may reflect an alter-
ation of the rules governing their physical interactions.
Furthermore, the territory spanned by single processes was
larger in KA-treated than control animals, which might re-
flect a compensation for shorter processes, allowing an effi-
cient scanning of the territory. These phenomena could be
due to the reduction of the signaling molecule(s) used for
mediating the repulsive interactions.
Conclusions
This study shows that, in contrast to other models of
microglial activation, the state of activation induced 48 h
after induction of SE does not hamper the sentinel role
of microglia. Indeed, they can still patrol the environ-
ment, and they can react to stimuli, possibly even in a
more efficient way. Furthermore, our study reveals that
microglia exhibit a variety of motility behaviors, which
are differentially affected by microglial activation, indi-
cating that the dynamic behavior of microglia depends
on their state of activation as well as the nature of the
stimulus, which triggers the motility.
Additional files
Additional file 1: Figure S1. Method to assess global velocity of
microglial processes. A Concentric rings are drawn around the area of
interest (laser lesion spot or 2Me-ADP-containing pipette) in the maximal
intensity projection (MIP) image. B Global velocity is calculated by observing
the fluorescent wave passing through the rings in the MIP video.
Each curve represents the evolution of the normalized fluorescence
in time in the corresponding ring (matched color in A).
Additional file 2: Figure S2. Example of hyper-activated microglial cells
in a slice obtained from a mouse with a long and severe crisis. Maximal
intensity projection of two-photon images of the CA1 region in a
hippocampal slice obtained from a KA-injected animal, which showed
a particularly severe crisis. Microglia almost completely retracted their
processes and accumulated around the stratum pyramidale, indicated
by the dotted line. Scale bar, 30 μm.
Additional file 3: Microglial response to P2Y12R agonist in control
animal. This movie shows the microglia response to a pipette containing
2Me-ADP in control animal. Processes distant as far as 100 μm responded
to the stimulus. The processes coordinate their response to form a circle
and arrive at the ATP analog source at the same time. New processes of
microglia closer to stimulus start to be formed but started to move only
after the more distal ones had caught up with them. Time expressed in
minutes. Images are maximal intensity projection over a stack of 20 μm.
Scale bar, 10 μm. Pixel sizes, 500, 300, and 200 nm.
Additional file 4: Microglial response to P2Y12R agonist in KA-
injected animal. This movie shows the microglia response to a pipette
containing 2Me-ADP in animal injected with KA. Comparing to control,
processes reach the target in about half time. Time expressed in minutes.
Images are maximal intensity projection over a stack of 20 μm. Scale bar,
10 μm. Pixel size, 250 nm.
Additional file 5: Microglial response to laser ablation in control
animal. This movie shows the microglia movement before and after a
small (1.6 × 1.6 μm) laser lesion (red spot) in control animal. Newly
formed processes grew out from the cell body and from existing
processes and moved towards the lesion site. Images are maximal
intensity projection over a stack of 10 μm. Time expressed in minutes
and seconds. Scale bar, 10 μm. Pixel size, 200 nm.
Additional file 6: Microglial response to laser ablation in KA-
injected animal. This movie shows the microglia response to a small
(1.6 × 1.6 μm) laser lesion (red spot) in KA-injected animal. In this movie,
we can see that the response is not completely synchronized and processes
do not approach the lesion site as a circle. Images are maximal intensity
projection over a stack of 10 μm. Time expressed in minutes and seconds.
Scale bar, 10 μm. Pixel size, 200 nm.
Additional file 7: Figure S3. Microglial processes converge towards a
2Me-ADP-containing pipette in a synchronized way. A–B Examples of
maximal intensity projection in the z direction and in time for 6 min
of two-photon images in slices where 2Me-ADP (100 μM)-containing
pipette have been introduced (at t = 0) in control (A) and 48 h after the
induction of a SE (B). Scale bar, 20 μm.
Additional file 8: Figure S4. The synchronization of microglial
processes is less evident in the movement induced by laser lesion.
Maximal intensity projections in the z direction and in time for 135 s
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(five time frames) of two-photon images in control. Processes arriving from
the cell on the left reached the lesion before other processes, and there is
no organization in circle as observed when a 2Me-ADP-containing pipette is
inserted (see Additional file 7: Figure S3).
Additional file 9: Figure 5. Activated microglia lose their spatial
segregated distribution. Three-dimensional reconstruction of 2-P image
stacks obtained in control (top row) and KA-injected (bottom row)
animals. Imaris software was used to reconstruct the morphology of single
microglial cells, and to each cell, a different color was associated. Scale grid,
10 μm.
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